{"id":"fenyramidol","rwe":[{"pmid":"5757516","year":"1968","title":"[Treatment with fenyramidol in muscular pain following administration of succinylcholine in patients undergoing obstetrical and gynecological surgical operations].","finding":"","journal":"Acta anaesthesiologica","studyType":"Clinical Study"},{"pmid":"14283370","year":"1965","title":"[PHARMACODYNAMIC STUDY OF A CENTRAL DEPRESSANT WITH MUSCLE RELAXANT PROPERTIES RELATED TO FENYRAMIDOL].","finding":"","journal":"Anesthesie, analgesie, reanimation","studyType":"Clinical Study"}],"tags":[{"label":"fenyramidol","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"M03BX30","category":"atc"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"cabral","offLabel":[],"synonyms":["phenyramidol","cabral","evasprin","fenyramidol","phenyramidol hydrochloride","phenyramidol HCl"],"timeline":[],"approvals":[],"brandName":"Cabral","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"fenyramidol","explanation":"Imagine your body's cells have locks on them, and the key to unlocking the right response is a specific molecule. Cabral is designed to fit that key, allowing it to turn the lock and trigger a response that helps treat a particular condition. This is a simplified explanation of how Cabral works at a molecular level.","oneSentence":"Cabral is thought to work by interacting with a specific molecular target to produce its therapeutic effect.","technicalDetail":"Fenyramidol is a small molecule that binds to a specific receptor or enzyme, modulating its activity to produce a therapeutic effect."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Fenyramidol","title":"Fenyramidol","extract":"Fenyramidol (INN) or phenyramidol, trade name Cabral, is a pharmaceutical drug which acts as a muscle relaxant."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2151","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=fenyramidol","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=fenyramidol","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Fenyramidol","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T11:16:43.846910","biosimilars":[],"competitors":[{"drugName":"baclofen","drugSlug":"baclofen","fdaApproval":"1977-11-22","patentExpiry":"Sep 8, 2037","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"tizanidine","drugSlug":"tizanidine","fdaApproval":"1996-11-27","patentExpiry":"May 7, 2042","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"cyclobenzaprine","drugSlug":"cyclobenzaprine","fdaApproval":"1977-08-26","patentExpiry":"Mar 14, 2034","patentStatus":"Patent protected","relationship":"same-class"}],"genericName":"fenyramidol","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"baclofen","brandName":"baclofen","genericName":"baclofen","approvalYear":"1977","relationship":"same-class"},{"drugId":"tizanidine","brandName":"tizanidine","genericName":"tizanidine","approvalYear":"1996","relationship":"same-class"},{"drugId":"cyclobenzaprine","brandName":"cyclobenzaprine","genericName":"cyclobenzaprine","approvalYear":"1977","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT04639869","phase":"PHASE1","title":"Bioequivalence Study of Feniramidol HCl 400 mg Film Tablet (Pharmactive, Turkey) Under Fed Conditions","status":"COMPLETED","sponsor":"Humanis Saglık Anonim Sirketi","startDate":"2019-06-26","conditions":["Bioequivalence"],"enrollment":44,"completionDate":"2019-08-27"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"001579","UNII":"R3V02WL7O3","CHEBI":"CHEBI:134888","INN_ID":"1204","UMLSCUI":"C1510448","ChEMBL_ID":"CHEMBL1697767","KEGG_DRUG":"D00755","DRUGBANK_ID":"DB13414","PUBCHEM_CID":"9470","SNOMEDCT_US":"83872005","SECONDARY_CAS_RN":"326-43-2","MESH_SUPPLEMENTAL_RECORD_UI":"C478450"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"M03BX30","allCodes":["M03BX30"]},"biosimilarFilings":[],"recentPublications":[{"date":"1968","pmid":"5757516","title":"[Treatment with fenyramidol in muscular pain following administration of succinylcholine in patients undergoing obstetrical and gynecological surgical operations].","journal":"Acta anaesthesiologica"},{"date":"1965 Jan-Mar","pmid":"14283370","title":"[PHARMACODYNAMIC STUDY OF A CENTRAL DEPRESSANT WITH MUSCLE RELAXANT PROPERTIES RELATED TO FENYRAMIDOL].","journal":"Anesthesie, analgesie, reanimation"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Fenyramidol, also known as Cabral, is a small molecule drug of the fenyramidol class. Its original development is not specified, and its current owner is unknown. The target and approved indications of Cabral are also unknown, and it has not been approved by the FDA. The commercial status of Cabral, including whether it is patented or generic, is also unknown. Further information on its pharmacokinetics, such as half-life and bioavailability, is also unavailable.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}